GlassScriptPhysician profile
Daniel Ray Elliott
NPI 1023004033
$788.40
in general payments reported to CMS, 2019-2025
9 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.88 · 2022: $100 · 2023: $67.71 · 2024: $242 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $365.68 | 2025 | Senza |
| Si-Bone, INC. | $113.10 | 2023-2024 | |
| Nevro Corp. | $110.46 | 2024 | Senza |
| Boston Scientific Corporation | $86.36 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.84 | 2023-2024 | Xifaxan |
| Mylan Specialty L.P. | $26.81 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.19 | 2023 | Seglentis, Livalo |
| Astellas Pharma US INC | $16.61 | 2023 | Veozah |
| Astrazeneca Pharmaceuticals LP | $16.35 | 2024 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.